Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Biomind Labs Applauds Landmark Executive Order Accelerating Psychedelic Research and Access in The United States
Brixton Metals Announces Upsize of Previously Announced Non-Brokered Private Placement to $8 Million and Closing of Second Tranche
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
